Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study-Reference-Cited by-同舟云学术

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study

Published:2019-07 Issue:7 Volume:18 Page:631-642
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Klopstock Thomas,Tricta Fernando,Neumayr Lynne,Karin Ivan,Zorzi Giovanna,Fradette Caroline,Kmieć Tomasz,Büchner Boriana,Steele Hannah E,Horvath Rita,Chinnery Patrick F,Basu Anna,Küpper Clemens,Neuhofer Christiane,Kálmán Bernadette,Dušek Petr,Yapici Zuhal,Wilson Ian,Zhao Feng,Zibordi Federica,Nardocci Nardo,Aguilar Christine,Hayflick Susan J,Spino Michael,Blamire Andrew M,Hogarth Penelope,Vichinsky Elliott

Funder

UK Medical Research Council

Wellcome Investigator Award

Newton Fund

European Research Council

Wellcome Trust Pathfinder Scheme

Wellcome Trust Principal Research Fellow

European Commission

Publisher

Elsevier BV

Subject

Clinical Neurology